Back
Speaker illustration

Associate Professor Mani Sadredini

University of Oslo, Oslo (Norway)

Presentations Articles

CaMKII as a therapeutic target in catecholaminergic polymorphic ventricular tachycardia type 1

Event: EHRA 2021

Topic: Arrhythmias

Session: Neurohormonal disturbances and arrhythmias

Access
Like
Thumbnail

CaMKII as a therapeutic target in catecholaminergic polymorphic ventricular tachycardia type 1

Event: EHRA 2021

Topic: Arrhythmias

Session: Oral abstract session - WGCCE

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources